Literature DB >> 32614957

Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan.

Mei-Hsuan Lee1, Yu-Han Huang1, Anna E Coghill2, Zhiwei Liu3, Kelly J Yu3, Wan-Lun Hsu4,5, Yin-Chu Chien5, Cheng-Ping Wang6, Tseng-Cheng Chen6, Chien-Jen Chen5, Allan Hildesheim3.   

Abstract

Nasopharyngeal carcinoma (NPC) is caused by Epstein-Barr virus (EBV) and is more likely to occur in susceptible families. Whether genetic susceptibility operates through altered EBV control is incompletely understood. We used a NPC risk prediction model based on 14 EBV markers to compare risk score distribution in unaffected members from multiplex families with that in population-based controls. Despite the absence of NPC at the time of antibody measurement, we observed an upward shift in risk score among multiplex family members compared to the general population, consistent with the possibility that genetic factors affect NPC risk through alterations in EBV control.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  genetic susceptibility; host-virus interactions; immune; multiplex antibody array; virus control

Year:  2021        PMID: 32614957      PMCID: PMC7982447          DOI: 10.1093/infdis/jiaa385

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan.

Authors:  Allan Hildesheim; Raymond J Apple; Chien-Jen Chen; Sophia S Wang; Yu-Juen Cheng; William Klitz; Steven J Mack; I-How Chen; Mow-Ming Hsu; Czau-Siung Yang; Louise A Brinton; Paul H Levine; Henry A Erlich
Journal:  J Natl Cancer Inst       Date:  2002-12-04       Impact factor: 13.506

2.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Authors:  Chien-Jen Chen; Hwai-I Yang; Jun Su; Chin-Lan Jen; San-Lin You; Sheng-Nan Lu; Guan-Tarn Huang; Uchenna H Iloeje
Journal:  JAMA       Date:  2006-01-04       Impact factor: 56.272

3.  Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.

Authors:  Allan Hildesheim; Denise L Doolan; Anna E Coghill; Ruth M Pfeiffer; Carla Proietti; Wan-Lun Hsu; Yin-Chu Chien; Lea Lekieffre; Lutz Krause; Andy Teng; Jocelyn Pablo; Kelly J Yu; Pei-Jen Lou; Cheng-Ping Wang; Zhiwei Liu; Chien-Jen Chen; Jaap Middeldorp; Jason Mulvenna; Jeff Bethony
Journal:  Clin Cancer Res       Date:  2018-01-04       Impact factor: 12.531

4.  Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants.

Authors:  Anna E Coghill; Wan-Lun Hsu; Qi Yang; Cheng-Ping Wang; Pei-Jen Lou; Kelly J Yu; Guoqin Yu; Scott R Diehl; Chien-Jen Chen; Alisa M Goldstein; Allan Hildesheim
Journal:  J Gen Virol       Date:  2018-07-05       Impact factor: 3.891

5.  Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families.

Authors:  Kelly J Yu; Wan-Lun Hsu; Ruth M Pfeiffer; Chun-Ju Chiang; Cheng-Ping Wang; Pei-Jen Lou; Yu-Juen Cheng; Patti Gravitt; Scott R Diehl; Alisa M Goldstein; Chien-Jen Chen; Allan Hildesheim
Journal:  Clin Cancer Res       Date:  2011-03-29       Impact factor: 12.531

6.  Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China.

Authors:  M F Ji; W Sheng; W M Cheng; M H Ng; B H Wu; X Yu; K R Wei; F G Li; S F Lian; P P Wang; W Quan; L Deng; X H Li; X D Liu; Y L Xie; S J Huang; S X Ge; S L Huang; X J Liang; S M He; H W Huang; S L Xia; P S Ng; H L Chen; S H Xie; Q Liu; M H Hong; J Ma; Y Yuan; N S Xia; J Zhang; S M Cao
Journal:  Ann Oncol       Date:  2019-10-01       Impact factor: 32.976

7.  Invited commentary: Epstein-Barr virus-based screening for the early detection of nasopharyngeal carcinoma: a new frontier.

Authors:  Allan Hildesheim
Journal:  Am J Epidemiol       Date:  2012-12-19       Impact factor: 4.897

8.  Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan.

Authors:  Amy Pickard; Chien-Jen Chen; Scott R Diehl; Mei-Ying Liu; Yu-Juen Cheng; Wan-Lun Hsu; Brenda Sun; Mow-Ming Hsu; I-How Chen; Jen-Yang Chen; Czau-Siung Yang; Beth L Mittl; Sheng-Ping Chou; Deborah D Ruggles; Alisa M Goldstein; Allan Hildesheim
Journal:  Int J Cancer       Date:  2004-08-10       Impact factor: 7.396

9.  Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan.

Authors:  Kelly J Yu; Wan-Lun Hsu; Chun-Ju Chiang; Yu-Juen Cheng; Ruth M Pfeiffer; Scott R Diehl; Alisa M Goldstein; Patti E Gravitt; Chien-Jen Chen; Allan Hildesheim
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

10.  A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).

Authors:  Rohina Rubicz; Robert Yolken; Eugene Drigalenko; Melanie A Carless; Thomas D Dyer; Lara Bauman; Phillip E Melton; Jack W Kent; John B Harley; Joanne E Curran; Matthew P Johnson; Shelley A Cole; Laura Almasy; Eric K Moses; Nikhil V Dhurandhar; Ellen Kraig; John Blangero; Charles T Leach; Harald H H Göring
Journal:  PLoS Genet       Date:  2013-01-10       Impact factor: 5.917

View more
  2 in total

1.  Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma.

Authors:  Zhiwei Liu; Yomani D Sarathkumara; John K C Chan; Yok-Lam Kwong; Tai Hing Lam; Dennis Kai Ming Ip; Brian C-H Chiu; Jun Xu; Yu-Chieh Su; Carla Proietti; Martha M Cooper; Kelly J Yu; Bryan Bassig; Raymond Liang; Wei Hu; Bu-Tian Ji; Anna E Coghill; Ruth M Pfeiffer; Allan Hildesheim; Nathaniel Rothman; Denise L Doolan; Qing Lan
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.996

Review 2.  SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target.

Authors:  Oscar Emanuel; Jacklyn Liu; Volker H Schartinger; Wen Long Nei; Yuk Yu Chan; Chi Man Tsang; Herbert Riechelmann; Liam Masterson; Johannes Haybaeck; Udo Oppermann; Stefan M Willems; Marc L Ooft; Guido Wollmann; David Howard; Bart Vanhaesebroeck; Valerie J Lund; Gary Royle; Melvin L K Chua; Kwok Wai Lo; Pierre Busson; Matt Lechner
Journal:  Cancers (Basel)       Date:  2021-09-30       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.